Oncopeptides AB (publ) (LON:0RN4)
London flag London · Delayed Price · Currency is GBP · Price in SEK
1.700
-0.102 (-5.66%)
At close: May 30, 2025

Oncopeptides AB Market Cap

Oncopeptides AB has a market cap or net worth of 28.96 million as of June 2, 2025. Its market cap has decreased by -45.03% in one year.

Market Cap
28.96M
Enterprise Value
30.96M
Revenue
3.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.70

Market Cap Chart

Since February 22, 2017, Oncopeptides AB's market cap has decreased from 149.07M to 28.96M, a decrease of -80.57%. That is a compound annual growth rate of -17.97%.

History

DateMarket Cap% Change
May 30, 202528.96M19.55%
Dec 30, 202424.23M-57.05%
Dec 29, 202356.41M-38.17%
Dec 30, 202291.23M76.11%
Dec 30, 202151.80M-94.99%
Dec 30, 20201.03B80.19%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 166.23B
HSBC Holdings 152.16B
Shell 145.59B
Unilever 117.27B
Rio Tinto Group 75.14B
RELX PLC 73.33B
British American Tobacco p.l.c. 73.04B
Rolls-Royce Holdings 72.41B
Market Cap Rankings